Researchers from Florida State University, Johns Hopkins University and the National Institutes of Health published a study Monday, Aug. 29, that identifies the first possible treatment for the Zika virus.
, which will still require further tests, showed that existing drugs (including Nicolsamide
, an FDA-approved drug for treating tapeworm), can stop the virus from replicating in the body and damaging fetal cells.
“We focused on compounds that have the shortest path to clinical use,” said FSU Professor of Biological Science Hengli Tang in a statement
. “This is a first step toward a therapeutic that can stop transmission of this disease.”
Tang and her colleges screened more than 6,000 compounds that were already approved by the FDA. The next step is to test the compounds on animals that already have the Zika virus.
You can read more about the research here